Fee Schedule For Pass-Through Payments Proposed In MedPAC March Report
This article was originally published in The Gray Sheet
Executive Summary
The possibility of manufacturers inflating new-technology device cost estimates within the hospital outpatient prospective payment system (OPPS) would be kept in check by CMS auditing practices, the Medicare Payment Advisory Commission (MedPAC) concludes in its March 2002 Report to Congress
You may also be interested in...
MedPAC Looking At Alternate Payment Mechanisms For New Technology
The Medicare Payment Advisory Commission is finding that coverage and cost components in paying for new medical technologies cannot be easily separated
MedPAC Looking At Alternate Payment Mechanisms For New Technology
The Medicare Payment Advisory Commission is finding that coverage and cost components in paying for new medical technologies cannot be easily separated
MedPAC Would Give CMS Responsibility For Creating National OPPS Rates
CMS would need to set national rates for all medical device "pass-through" payments under one of the Medicare Payment Advisory Commission's (MedPAC) recommendations on the future of the outpatient prospective payment system (OPPS)